March 25, 2020 / 6:10 AM / 14 days ago

BRIEF-Oasmia Pharmaceutical And Elevar Sign Partnership Deal

March 25 (Reuters) - Oasmia Pharmaceutical AB:

* OASMIA PHARMACEUTICAL AB AND US BASED ELEVAR THERAPEUTICS INC. HAVE SIGNED A GLOBAL STRATEGIC PARTNERSHIP DEAL REGARDING COMMERCIALIZATION OF OASMIA’S ANTICANCER PRODUCT APEALEA®

* ELEVAR WILL ALSO PAY OASMIA DOUBLE-DIGIT ROYALTIES ON SALES OF APEALEA® Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below